INTRODUCTION In current study we assessed the effect of transcutaneous electrical acupoint stimulation (TEAS) on the quality of early recovery in patients undergoing gynecological laparoscopic surgery. METHODS Sixty patients undergoing gynecological laparoscopic surgery were randomly assigned to TEAS (TEAS group) or control group (Con group). TEAS consisted of 30 min of stimulation (12-15 mA, 2/100 Hz) at the acupoints of Baihui (GV20), Yingtang (EX-HN-3), Zusanli (ST36) and Neiguan (PC6) before anesthesia. The patients in the Con group had the electrodes applied, but received no stimulation. Quality of recovery was assessed using a 40-item questionnaire as a measure of quality of recovery (QoR-40; maximum score 200) scoring system performed on preoperative day 1 (T0), postoperative day 1 (T1) and postoperative day 2 (T2); 100-mm visual analogue scale (VAS) scores at rest, mini-mental state examination (MMSE) scores, the incidence of nausea and vomiting, postoperative pain medications, and antiemetics were also recorded. RESULTS QoR-40 and MMSE scores of T0 showed no difference between two groups (QoR-40: 197.50 ± 2.57 vs. 195.83 ± 5.17), (MMSE: 26.83 ± 2.74 vs. 27.53 ± 2.88). Compared with the Con group, QoR-40 and MMSE scores of T1 and T2 were higher in the TEAS group (P < 0.05) (QoR-40: T1, 166.07 ± 8.44 vs. 175.33 ± 9.66; T2, 187.73 ± 5.47 vs. 191.40 ± 5.74), (MMSE: T1, 24.60 ± 2.35 vs. 26.10 ± 2.78; T2, 26.53 ± 2.94 vs. 27.83 ± 2.73). VAS scores of T1 and T2 were lower (P < 0.05) in the TEAS group (T1, 4.73 ± 1.53 vs. 3.70 ± 1.41; T2, 2.30 ± 0.95 vs. 1.83 ± 0.88); the incidence of postoperative nausea and vomiting (PONV), remedial antiemetics and remedial analgesia was lower in the TEAS group (P < 0.05) (PONV: 56.7% vs. 23.3%; incidence of remedial antiemetics: 53.3% vs. 23.3%; incidence of remedial analgesia: 80% vs. 43.3%). CONCLUSION The use of TEAS significantly promoted the quality of early recovery, improved MMSE scores and reduced the incidence of pain, nausea and vomiting in patients undergoing gynecological laparoscopic surgery. TRIAL REGISTRATION ClinicalTrials.gov, NCT02619578. Registered on 2 December 2015. Trial registry name: https://clinicaltrials.gov.

中文翻译：

---

TEAS对接受妇科腹腔镜手术的患者早期恢复质量的影响：一项前瞻性，随机，安慰剂对照试验。

引言在目前的研究中，我们评估了经皮电穴位刺激（TEAS）对妇科腹腔镜手术患者早期康复质量的影响。方法将60例行妇科腹腔镜手术的患者随机分为TEAS组（TEAS组）或对照组（Con组）。TEAS麻醉前在百会（GV20），营堂（EX-HN-3），祖三里（ST36）和内关（PC6）的穴位进行30分钟的刺激（12-15 mA，2/100 Hz）。Con组的患者已应用电极，但未受到刺激。使用40项问卷作为恢复质量评估（QoR-40；最高分200），在术前1天（T0），术后1天（T1）和术后2天（T2）进行评估，评估恢复质量）; 还记录了静止时100毫米视觉模拟量表（VAS）评分，小精神状态检查（MMSE）评分，恶心和呕吐的发生率，术后镇痛药物和止吐药。结果T0的QoR-40和MMSE得分在两组之间没有差异（QoR-40：197.50±2.57对195.83±5.17），（MMSE：26.83±2.74对27.53±2.88）。与Con组相比，TEAS组T1和T2的QoR-40和MMSE得分更高（P <0.05）（QoR-40：T1，166.07±8.44 vs. 175.33±9.66; T2，187.73±5.47 vs. 191.40±5.74），（MMSE：T1，24.60±2.35 vs. 26.10±2.78； T2，26.53±2.94 vs. 27.83±2.73）。TEAS组的T1和T2的VAS评分较低（P <0.05）（T1，4.73±1.53对3.70±1.41; T2，2.30±0.95对1.83±0.88）; 术后恶心呕吐的发生率 TEAS组的补救性止吐药和补救性镇痛作用较低（P <0.05）（PONV：56.7％vs. 23.3％；补救性止吐药的发生率：53.3％vs. 23.3％；补救性镇痛的发生率：80％vs. 43.3％） 。结论TEAS的使用显着提高了妇科腹腔镜手术患者的早期恢复质量，改善了MMSE评分并降低了疼痛，恶心和呕吐的发生率。试验注册ClinicalTrials.gov，NCT02619578。于2015年12月2日注册。试验注册名称：https：//clinicaltrials.gov。改善妇科腹腔镜手术患者的MMSE评分并减少疼痛，恶心和呕吐的发生率。试验注册ClinicalTrials.gov，NCT02619578。于2015年12月2日注册。试验注册名称：https：//clinicaltrials.gov。改善妇科腹腔镜手术患者的MMSE评分并减少疼痛，恶心和呕吐的发生率。试验注册ClinicalTrials.gov，NCT02619578。于2015年12月2日注册。试验注册名称：https：//clinicaltrials.gov。